- NCI Designation
- Message from the Director
- Board Chair and Vice Chairs
- Leadership
- 2019: Sylvester by the Numbers
- Recruits and New Appointments
-
- NCI Funds Sylvester Research Aimed at Improving Selection of Patients for Prostate Biopsy
- Graduate Student in Cancer Biology Receives Early - Career Recognition and Awards
- Sylvester Researchers Receive Grant from Hyundai Hope On Wheels®
- Two Pancreatic Cancer Researchers Awarded Grants from the Florida Department of Health
- American Cancer Society Awards Five-Year Grant to Urologic Surgeon
-
- A Paradigm Shift for Hard-to-Treat Sarcomas
- Researcher Identifies Potential Target for Treating Aggressive Brain Tumors in Children
- Mast Clinical Trial Focuses on Progression Rate of Prostate Cancer
- Epigenetic Changes May Explain How Aging Increases Blood Cancer Risks
- Eye Cancer Researchers at Sylvester and Bascom Palmer Identify Function of Key Tumor Suppressor
- Sylvester Researchers Discover a Possible Pathway for Immune Therapy in Pancreatic Cancer
- Sylvester Researchers Uncover Why PARP Inhibitors Could Be a New Treatment Option for a Common Lymphoma
- Liver Cancer Disparities: A Complicated Picture
- New Trial Targets Lymphoma from Two Directions
- Clinical Trial Explores Effectiveness of New Treatment for Patients with Bladder Cancer
- Sylvester Research Identifies Novel Vulnerability in Acute Leukemia Cells
- Promising Findings by Sylvester Researchers Point to New Therapeutic Target for Advanced Prostate Cancer
-
- Dr. Stephen D. Nimer Honored with Endowed Chair
- Cyclotron Arrives at Sylvester Comprehensive Cancer Center
- Dr. Charles Vogel Wins Health Care Heroes Lifetime Achievement Award
- Graduate Student Wins Prestigious NCI Transition Award
- Dr. Justin Watts Honored with The Pap Corps Endowed Professorship in Leukemia
- Seven Sylvester Faculty Members Receive Awards at Zubrod Memorial Lecture
- Sylvester Joins Precision Oncology Alliance to Share Data, Further Cancer Research
- Sylvester Investigator Wins Prestigious Award for Advancing Urologic Research
- Sylvester’s Radiation Oncology Team Earns Prestigious Press Ganey Award
- Sylvester Again Recognized for Setting the Standard in Cancer Data Collection
- Sylvester Receives Trailblazer Award from Miami Chamber
- Cancer Survivorship
-
71st
NCI-Designated Cancer Center in the Country.
1 of 2
NCI-Designated cancer centers in Florida.
335
Physicians and scientists devoted exclusively to cancer care and research.
1,430
Stem cell transplants completed since program's inception.
4,292
Patients participating in 330 clinical studies (interventional and non-interventional).
7
Treatment facilites across South Florida.
13
Cancer site disease groups.
30
13 Cancer support services and 17 cancer support groups.
8,000
Cancer patients treated.
5,803
New patients (analytic cases - CY 2018).
297
Cancer relevant peer-reviewed publications, 82 with other NCI-Designated cancer centers.
$42.9M
Peer-reviewed and non-peer-reviewed funding for 384 active cancer projects:
$25.5M peer-reviewed
($10.4M from NCI)
$2.2M for training grants (additional)
